Voxware Cleans House

DotPhoto Funding

Stock Roundup

More Stock News

Deaths

Corrections or additions?

These articles were prepared for the January 7, 2004 issue of U.S.

1 Newspaper. All rights reserved.

Life in the Fast Lane

After more than 30 years of serving drinks and food in a convivial

atmosphere, the Rusty Scupper has left port, headed for uncharted

waters. The 50-person staff had less than two days notice of the

shut-down on Saturday, January 3. No decision has been made about what

will be done with the building, whether it will continue as a

restaurant or be used for another purpose.

"The property is not for sale," says Toby Laughlin, a realtor who is a

part owner. "I am talking to various people, but it is at a

preliminary stage, and I’m open to everything right now."

Laughlin declined to be specific about why the national restaurant

chain did not renew its lease. "As in any sort of landlord/tenant

situation, you renegotiate rents from time to time, and it was a

matter of not getting together on that."

The parent company, Select Restaurant Inc. in Cleveland, Ohio, says it

is looking for a new location in Princeton. It owns the liquor license

and has told Princeton Township that the license will go on inactive

status until it is placed at another location or sold.

Like many restaurants in the area, the Scupper seemed to have lost

some business after 9/11. But the owners had been moving aggressively,

with marketing efforts that included a billboard on Route 1, and a new

chef had recently been installed. The Scupper’s second floor was a

gathering place for many professional clubs and singles groups. Last

fall General Wesley Clark’s New Jersey campaign hosted a fundraiser

there.

Laughlin says he regrets the restaurant’s closing: "Over the years

we’ve had a great relationship with the Rusty Scupper." The 10,000

square foot property was built in 1972 for the Rusty Scupper chain by

Laughlin’s father and another partner. Although Princeton University

owns a small part of the parking lot, and New Jersey Transit has a

right of way through the property, the major part of the land and all

of the buildings is owned half by the Laughlin family, and half by

another family.

A graduate of the Hun School and Colorado College, Class of 1972,

Laughlin has a business, Laughlin Real Estate, on Tamarack Circle in

Skillman and focuses on commercial and residential property management

and development. Formerly he had been developing apartments, but now

he concentrates on telecommunications towers. He sold his first firm,

Princeton Towers Pennsylvania, which had 50 towers, and currently owns

about 20 towers.

Maybe the Scupper’s problem was that it was neither "here nor there,"

neither downtown Princeton, where it could attract foot traffic, or on

Route 1, where it would get more visibility.

Top Of Page
Voxware Cleans House

Even though 10-year-old Voxware has had success in landing financing,

getting contracts, and increasing revenues, the company’s CEO,

Bathsheba J. Malsheen, is leaving and the CFO, Nicholas Narlin,

resigned last month.

Founded by Michael Goldstein in 1993, Voxware’s current business is

integrated voice-based solutions for distribution and logistics

operations. While the stock sometimes dipped below $1 in its early

years, it has been trading below 20 cents for the past two years. Yet

its revenues doubled from $4 million to $8 million last year. One of

the two biggest investors in the company is Lenox Drive-based Edison

Venture Fund.

The new CEO is Thomas J. Drury, a venture capitalist who has had great

success with Sensar Inc., the Moorestown-based biometrics company that

spun off from Sarnoff Corporation. An alumnus of St. Peter’s College,

he was CEO in 1998 during Sensar’s strong growth period, and has also

been CEO of Micro Dynamics, a document imaging software firm, and Urix

Corp., a voice processing equipment and software company. Drury’s most

recent venture capital firm, BaseCamp 1, is not an investor in

Voxware, says a Voxware spokesperson.

In December 2003 the Voxware landed a $2 million loan from Silicon

Valley Bank to pay off debt and make investments in sales, marketing,

and customer service programs. The loan is secured by the two biggest

stockholders, Edison Venture Fund V and Cross Atlantic Technology Fund

II.

Counting on the company to be profitable in Western Europe, Edison and

the other venture capitalists had led a $5.6 million round of private

financing in June, 2003. Sure enough, on January 5, Voxware announced

that its VoiceLogistics warehouse system is going to be used by a top

global retailer, the French firm Intermarche. Other contracts have

been signed with CooperVision, 7-Eleven, and US Food Service.

Voxware’s controller, Allen M. Adler, has been filling in as interim

CFO since Narlis resigned last month. The stock traded at $.037 on

December 31, 2002, and at $.13 on December 31, 2003.

Voxware Inc. (VOXW.OB), 168 Franklin Corner Road,

Suite

3, Lawrenceville 08648. 609-514-4100; fax, 609-514-4101. Home page:

www.voxware.com

Top Of Page
DotPhoto Funding

Glenn Paul’s web-based digital photo processing company, Dotphoto.com,

landed $4 million in venture capital funding on New Year’s Day.

Lenox-Drive based Edison Venture Fund led the round with $3 million,

and Sycamore Ventures, on Vaughn Drive, chipped in $1 million. The

company is privately held.

Dotphoto.com, 800 Silvia Street, American Enterprise at

Ewing, Ewing 08628. Glenn Paul, founder. 609-434-0340; fax,

609-434-0344. Home page: www.dotphoto.com

Top Of Page
Stock Roundup

The bulls are on the run, and Princeton-area companies are right in

step. Nearly all of our publicly-traded companies posted gains in

2003. The good news covered young biotechs, some of which were up 300

percent and more, as well as vulnerable oldsters like Church & Dwight.

Powered by newly redesigned kitty litter, among other well-received

products, it moved ahead a solid 30 percent. Banks did well, as did

publishers. Results were mixed for technology companies, but many,

like Universal Display Corporation and ITXC Corp., moved solidly

ahead.

Perhaps better yet, in their most recent filings with the Securities

and Exchange Commission (SEC), even companies that are still lagging

reported that orders are up. After a bruising recession, few companies

are euphoric, but most are at least cautiously optimistic.

Church & Dwight Co. Inc. (CHD), 469 North Harrison

Street, CN 5297, Princeton 08543-5297. Robert A. Davies III, chairman

and CEO. 609-683-5900; fax, 609-497-7177. Home page: www.armhammer.com

Stock price on December 31, 2002: $30.43

Stock price on December 31, 2003: $39.60

Reporting positive results for its most recent quarter on November 3,

2003, the baking powder power said it had posted a 10 percent increase

over the prior period. The company’s liquid laundry products are

flying off the shelves, offsetting poorer sales of dry laundry

products. Other earnings spikes came as a result of the introduction

of new cat litter and carpet deodorized products, while cleaner sales

were dampened by a safety recall of an item from the company’s Sno Bol

toilet bowl cleaner line.

Congoleum Corporation (CGM), 3500 Quakerbridge

Road, Box

3127, Mercerville 08619. Roger Marcus, president, CEO. 609-584-3000;

fax, 609-584-3685. Home page: www.congoleum.com

December 31, 2002: $.42

December 31, 2003: $.68

On the last day of the year, the floor covering maker filed a

prepackaged bankruptcy plan, saying that it had garnered needed

support from asbestos claimants. The markets reacted favorably,

sending the company’s stock over $1.

Congoleum said it plans to seek quick confirmation of the plan, filed

in U.S. Bankruptcy Court in Trenton to resolve claims related to its

use of asbestos decades ago in flooring products.

According to a Reuters report, when the reorganization plan is

confirmed, Congoleum will contribute certain insurance rights and a

note for about $2.7 million to a trust for asbestos personal injury

claimants. The plan also calls for Congoleum’s other creditors to be

paid in full and for shareholders to retain their stake in the

company.

The Trenton-based company said it expected to record a $3.7 million

fourth-quarter charge to boost its reserve for estimated costs

required to complete its reorganization.

The company began soliciting final approval for the Chapter 11

reorganization plan in October.

The vinyl floor maker has 694 employees at two facilities in Trenton

and 442 at factories in Pennsylvania and Maryland.

Covance Inc. (CVD), 206 Carnegie Center, Princeton

08540-6681. Chris Kuebler, chairman and CEO. 609-452-8550; fax,

609-452-9375. Home page:

www.covance.com

December 31, 2002: $24.59

December 31, 2003: $26.80

Covance’s third quarter earnings jumped 24 percent over earnings in

the same quarter one year ago.

In filing the results with the SEC, Chris Kuebler, chairman and CEO,

said that "ongoing productivity improvements drove increased

profitability and earnings." Results were especially strong in the

drug discovery company’s Early Development unit, which posted

operating margins of 22 percent, top line growth of 11.6 percent, and

strong new order flow.

The drug development service company has operations in 17 countries

and 6,900 employees worldwide. It is pulling in an increasing number

of large, multi-capability projects, as net orders have increased for

two quarters in a row. It sees market dynamics on the upswing.

Cytogen Corporation (CYTO), 650 College Road East,

Suite

3100, Princeton 08543-5308. Michael Becker, president and CEO.

609-750-8200; fax, 609-452-2476. Home page: www.cytogen.com

December 31, 2002: $3.25

December 31, 2003: $10.88

Cytogen, a product-driven, oncology-focused biopharmaceutical,

reported a steep increase in revenue for third quarter 2003, to $5.51

million from $3.10 million in the year-ago period. While the company

is still losing money, it is doing so at only half the rate of one

year ago, and reports sufficient cash on hand to take it through at

least 2005.

The year saw the reacquisition of marketing rights to key product

Quadrament, and a marketing realignment whereby the company will sell

NMP22 PladderChek in the U.S. exclusively to oncologists after

December 31, 2003. The company’s strategy is to devote sales and

marketing resources to products with significantly higher gross

margins.

Also on a positive note, Cytogen is "cautiously optimistic" that

encouraging clinical data will lead to approval of Combidex, a novel

lymph node imaging agent developed by Advanced Magnetics, which it

intends to market pending clearance by the U.S. FDA.

Dataram Corp. (DRAM), 186 Princeton-Hightstown

Road,

Windsor Business Park, Building 2-A, Box 7528, Princeton 08543-7528.

Robert V. Tarantino, CEO. 609-799-0071; fax, 609-936-1369. Home page:

www.dataram.com

December 31, 2002: $3.09

December 31, 2003: $4.20

Dataram, in the computer memory business, saw an increase in orders in

its second quarter, ended October 31, 2003. Robert V. Tarantino, the

company’s chairman and CEO, in releasing the results, commented that

"We are encouraged by recent improvements in our level of business.

Our order rate improved in the second quarter, particularly in the

latter part of the quarter."

Margins were up, too, as prices of certain DRAMs increased.

The company sees improvement in demand, "albeit sporadic," going

forward in the new year.

Derma Sciences Inc. (DSCIOB), 214 Carnegie Center,

Suite

100, Princeton 08540. Edward J. Quilty, CEO. 609-514-4744; fax,

609-514-0502. Home page: www.dermasciences.com

December 31, 2002: $.75

December 31, 2003: $.40

Derma Sciences, a manufacturer and full line supplier of wound and

skin care products, reported a net sales increase of 33 percent for

its third quarter, ended September 30, 2003. Sales of $4.2 million

compared with sales of $3.2 million in third quarter 2002.

Net loss for the quarter was $.01 per basic and diluted common share.

Edward J. Quilty, president and CEO, commented, "We continue to make

measured progress quarter over quarter, but realize there is still

considerable work to be accomplished to drive profitability to a level

consistent with our potential." He added that new contracts and the

launch of new products "position us well to achieve our goals" in the

new year.

Exide Technologies (EXDTQ), 210 Carnegie Center,

Princeton 08540. Craig Muhlhauser, president and COO. 609-627-7200;

Home page: www.exideworld.com

December 31, 2002, $.275

December 31, 2003, $.025

Exide tried to reorganize by filing for Chapter 11 bankruptcy but the

U.S. Bankruptcy Court for the District of Delaware nixed the company’s

proposal. The court said the company put too low a value on its

holdings. A report on the company’s negotiations with its creditors is

due on January 22.

With operations in 89 countries and net sales last year of

approximately $2.4 billion, Exide Technologies is one of the worlds

largest producers and recyclers of lead-acid batteries. It has two

major groups, industrial energy and transportation.

Integra LifeSciences Holdings Corporation (IART),

311

Enterprise Drive, Plainsboro 08536. Stuart M. Essig, president/CEO.

609-936-3600; fax, 609-936-2263. Home page: www.integra-ls.com

December 31, 2002: $17.65

December 31, 2003: $28.66

Integra, which develops, manufactures, and markets medical devices for

use primarily in neuro-trauma and neurosurgery, plastic, and

reconstructive surgery, had a good year. In line with its strategy of

growing through acquisitions, it acquired the assets of Tissue

Technologies in August; it acquired J. Jamner Surgical Instruments in

March; and it acquired the epilepsy monitoring and neurosurgical shunt

business of the Radionics division of Tyco Healthcare Group in

December 2002.

The company posted a 56 percent increase in revenue for third quarter

2003 as compared with the year ago period. In its SEC filing, Integra

stated that it expects "future growth will be driven by our expanded

product lines, domestic and international sales and marketing

organizations, and distribution channels."

The company is also seeking to grow its bottom line going forward

through still more acquisitions in areas that complement existing

products and operations.

ITXC Corp. (ITXC), 750 College Road East, Princeton

08540. Tom Evslin, chairman and CEO. 609-750-3333; fax, 609-419-1511.

Home page: www.itxc.com

December 31, 2002, $2.32

December 31, 2003, $4.31

Six years after Tom Evslin founded this Internet telephony company, he

announced it would be sold to a Montreal-based firm, Teleglobe, a

traditional telco that has just emerged from Chapter 11 bankruptcy.

The sale, expected to take place this year, will help update the

Canadian company, a former division of Bell Canada that trades on the

New York Stock Exchange as TGO. Meanwhile the web-based voice business

will continue to operate from ITXC’s current headquarters on College

Road. Evslin has said he wants to retire.

ITXC has carried nearly 10 billion minutes of voice service to carrier

customers around the world. In the fourth quarter of 2003 it hit the

one billion minute mark.

Interpool (IPX), 211 College Road East, Princeton

08540.

Martin Tuchman, chairman and CEO. 609-452-8900; fax, 609-452-8211.

Home page: www.interpool.com

Shareholders of Interpool are still waiting for audited statements for

2000 through 2002, but on January 15 they will get their usual

quarterly dividend of $.0625 cents per share, worth $1.7 million.

After the Arthur Andersen accounting scandals, Interpool fired its

accounting team, and then the chief financial officer and president

resigned when an outside law firm discovered irregularities that

caused the reporting delays. Interpool says that when it reveals the

changes, they will be minimal, but the Securities and Exchange

Commission has begun an investigation. Reports for 2000, 2001 and 2002

show that the cargo container leasing business remains profitable,

Chairman Martin Tuchman assumed the president’s duties and said that

the report showed the former president, Raoul Witteveen, authorizing

transactions that would have improperly increased earnings, but that

the financial statements did not contain any misstatement as a result

of these transactions.

James F. Walsh will officially be Interpool’s new chief financial

officer on April 1, and until then he is working at the company in

other capacities. Richard Gross is interim chief financial officer.

With 100 workers at the College Road headquarters, Interpool is the

world’s largest lessor of intermodal container chassis and a

world-leading lessor of cargo containers used in international trade.

Johnson & Johnson (JNJ), 1 Johnson & Johnson Plaza,

New

Brunswick 08933. William C. Weldon, chairman & CEO. 732-524-0400; fax,

732-214-0332. Home page: www.jnj.com

December 31, 2002: $53.71

December 31, 2003: $51.66

The financial press is beginning to label pharma giant J&J a bargain.

Results are robust, but, like many pharmaceuticals, its stock price

has been lagging.

For the nine months ended September 30, 2003, the company racked up

overall sales of $30.6 billion, up 13.8 percent from the year ago

period. Domestic sales, at $18.5 billion, were up 10.9 percent.

Increases came in across the board, in both consumer and

pharmaceutical divisions.

A lawsuit by medical technology company Conmed claiming anti-trust

practices hurt J&J’s stock price as the fourth quarter drew to an end.

Conmed claims that J&J has used unfair tactics to corner 60 percent of

the $1 billion market for endoscopy surgical devices used in minimally

invasive surgery.

Another concern for investors: Questions over the safety of the

company’s Cypher stents used in angioplasty procedures.

Medarex Inc. (MEDX), 707 State Road, Princeton

08540.

Donald L. Drakeman, CEO. 609-430-2880; fax, 609-430-2850. Home page:

www.medarex.com

December 31, 2002, $3.95

December 31, 2003, $6.23

Medarex and its licensees have 16 fully-human antibodies that are

either being used in human clinical trials or are in the applications

stage. All of these antibodies have been derived from Medarex’s

UltiMAb mouse.

The most recent antibody, from Genmab, is for the treatment of

non-Hodgkin’s lymphoma. Medarex has five of the antibody therapeutics

under development by Medarex for diseases that include melanoma,

prostate cancer, breast cancer, HIV, Hodgkin’s lymphoma, and

anaplastic large cell lymphoma as well as autoimmune diseases. Other

licensees, including Centocor/J&J and Novartis, are developing fully

human antibodies for diseases such as cancer, lymphoma, rheumatoid

arthritis, and other autoimmune diseases.

Pharmacopeia Inc. (PCOP), 3000 Eastpark Boulevard,

CN

5350, Princeton 08543-5350. Joseph A. Mollica, CEO. 609-452-3600; fax,

609-452-3672. Home page: www.pcop.com

December 31, 2002, $8.92

December 31, 2003, $14.23

Pharmacopeia will restructure itself and split its software operations

from its drug discovery division. The software accounted for $95

million of $125 million in sales in 2002.

The drug discovery business will stay on Eastpark Boulevard, as will

CEO Joseph Mollica and 170 employees. It does proprietary small

molecule combinatorial and medicinal chemistry, high-throughput

screening, in-vitro pharmacology, computational methods and

informatics to discover and optimize lead compounds.

Its software subsidiary, Accelrys, which has 530 employees in San

Diego, develops and commercializes molecular modeling and simulation

software for the life sciences and materials research markets,

cheminformatics and decision support systems, and bioinformatics

tools, including gene sequence analysis.

Tyco International Ltd. (TYC), 9 and 7 Roszel Road,

Princeton 08540. Edward Breen, CEO. 609-720-0024. Home page:

www.tyco.com

December 31, 2002, $17.08

December 31, 2003, $26.50

Operating in more than 100 countries, Tyco is officially based in

Bermuda but has moved its United States headquarters to Roszel Road.

Tyco’s chief financial officer, David FitzPatrick, has said he wants

to halve the company’s debt to about $10-$12 billion and then use cash

to make acquisitions.

The former chairman, Dennis Kozlowski, is being tried on charges that

he and former CFO Mark Swartz wrongfully took $600 million from the

firm.

Having spent $60 billion to acquire hundreds of companies, Tyco is the

world’s leading provider of electronic security services, fire

protection services, passive electronic components, and industrial

valves and controls. It also has undersea fiber optic networks and

services, medical products, and plastics and adhesives. Revenues from

continuing operations in 2003 were about $37 billion.

Xechem Inc./Xechem International Inc. (XKEM), 100

Jersey

Avenue, Building B, Suite 310, New Brunswick 08901-3279. Ramesh C.

Pandey, CEO. 732-247-3300; fax, 732-247-4090. Www.xechem.com

December 31, 2002, $.0008

December 31, 2003, $.155

Xechem International Inc. has bought a privately held biotech company,

Ceptor Inc., for $6 million in stock. Xechem assumed $300,000 in debt.

The Brooklyn-based Ceptor will be a wholly-owned subsidiary of Xechem.

Its lead product inhibits the primary protease that degrades skeletal

muscle and might be used to treat muscular dystrophy. A clinical trial

for muscular dystrophy could begin this year.

Xechem International, Inc. is a fully integrated biopharmaceutical

company focusing on proprietary technologies for orphan diseases.

Top Of Page
More Stock News

Amersham Health (AHM), 101 Carnegie Center, Princeton

08540. Daniel L. Peters, president. 609-514-6000; fax, 609-514-6572.

Home page: www.amershamhealth.com

December 31, 2002, $44.40

December 31, 2003, $68.28

Headquarters of R&D, manufacturing, and marketing firm operating in

the western hemisphere, with a specialty in medical diagnostics and

radiotherapy products, formerly Nycomed Amersham.

Guest Supply Inc. (GSY), 4301 Route 1 South, Princeton

Executive Center, Box 902, Monmouth Junction 08852-0920. Clifford

Stanley, president, CEO. 609-514-9696; fax, 609-514-2692.

December 31, 2002: $14.28

December 31, 2003: $18.47

Design, marketing, and manufacturing for hotel amenities and cleaning

supplies.

Journal Register Co. (JRC), 50 West State Street, 12th

Floor, Trenton 08608-1298. Robert M. Jelenic, chairman, president and

CEO. 609-396-2200; fax, 609-396-2292. Home page:

www.journalregister.com

December 31, 2002, $17.78

December 31, 2003, $20.70

Newspaper publishing, owner of the Trentonian, New Haven Register, and

22 other daily and 204 non-daily publications.

NexMed (USA) Inc. (NEXM), 350 Corporate Boulevard,

Robbinsville 08691. Joseph Mo, chairman, CEO, and president.

609-208-9688; fax, 609-208-1868. Home page: www.nexmed.com

December 31, 2002, $.71

December 31, 2003, $3.99

Development of NexACT transdermal drug delivery technology – Alprox-TD

and Femprox creams for ED and female sexual arousal disorder,

respectively

Opinion Research Corporation (OPI), 600 College Road,

Fourth Floor, Box 183, Princeton 08542-0183. John Short, CEO.

908-281-5100; fax, 908-281-5103. Home page: www.opinionresearch.com

December 31, 2002, $5.60

December 31, 2003, $6.37

A global measurement-based marketing services firm with fact-based

market intelligence, with 200 people in the United States.

Palatin Technologies Inc. (PTN), 4C Cedar Brook Drive,

Cedar Brook Corporate Center, Cranbury 08512. Carl Spana PhD,

president & CEO. 609-495-2200; fax, 609-495-2201. Home page:

www.palatin.com

December 31, 2002, $1.98

December 31, 2003, $2.50

Products for sexual dysfunction and appendicitis detection, also

product to facilitate ultrasound testing.

RCN Corporation (RCNC), 105 Carnegie Center, Princeton

08540. David C. McCourt, chairman and CEO. 609-734-3700; fax,

609-734-4586. Home page: www.rcn.com

December 31, 2002, $.53

December 31, 2003, $.68

A national single-sourced facilities-based competitive provider of

bundled phone, cable television, and high-speed Internet services

Senesco Technologies Inc. (SNT), 303 George Street, Suite

420, New Brunswick 08901. Bruce C. Galton, CEO. 732-296-8400; fax,

732-296-9292. Home page: www.senesco.com

December 31, 2002, $2.10

December 31, 2003, $3.31

Agrobiotechnology – developing gene technology to extend the

shelf-life of produce, regulating the onset of cell death

Wave Systems Corp. (WAVX), 101 Morgan Lane, Third Floor,

Plainsboro 08536. Kenneth Hoeg, vice president applications

engineering. 609-750-1600; fax, 609-750-1480. Home page:

www.wavesys.com

December 31, 2002, $1.33

December 31, 2003, $1.64

Developer of chip called the WaveMeter that monitors computer,

software, and/or information service usage through encryption and

metering technology.

WorldWater Corp. (WWAT), 55 Route 31 South, Pennington

Business Park Building B, Pennington 08534. Quentin T. Kelly, CEO.

609-818-0700; fax, 609-818-0720. Home page: www.worldwater.com

December 31, 2002, $.16

December 31, 2003, $.135

Principal supplier of renewable energy and remote water supply for

emerging nations – water management and solar energy company,

designing, developing and marketing proprietary technology

head @14 = Crosstown Moves

Uniglobe All Around Travel, 11 Princeton Avenue, Hopewell

08525. Kristine Toth, owner/manager. 609-466-2700; fax, 609-466-5681.

Www.uniglobeallaroundtravel.com

Uniglobe All Around Travel has moved from 2 Mercer Street in Hopewell

to 11 Princeton Avenue in Hopewell. Owner Kristine Toth says the new

quarters are more cost efficient. She also reports that her retail

clients are heading "anywhere warm" during the upcoming holidays.

Business is brisk, and many prime resorts are completely sold out.

Cruises are especially popular.

Meanwhile, business travel at her 32-year-old agency, which she has

owned for five years is way up. "It’s doubled since January," she

says.

Avery Schlueter, 222 Commons Way, Princeton 08540.

Cynthia A. Avery, president. 609-921-9111; fax, 609-921-0095.

Cynthia Avery and Edward Schlueter have moved their recruiting firm to

from the first floor to the second floor in order to have more privacy

at Montgomery Commons. Focusing on packaging and food processing

machinery, and pharmaceutical processing industries, they search

nationally for senior sales and marketing positions, general

management, and presidents.

Schlueter graduated with a chemistry major from Hunter, College in

1964 and has a master’s degree in management from at Brooklyn

Polytech. He had worked at InterChemical, Tidland Corporation, and Big

Three Industries (a Houston-based conglomerate), and moved to

Princeton in 1989. His wife, Avery, had been a biochemistry major at

Wheaton College in Massachusetts and had worked for American Cyanamid

and Celanese before going into the recruiting business 25 years ago.

She and her husband opened their business in 1978.

Top Of Page
Deaths

Tomako Nakayama, 66, on December 26. She had been a staff advisor at

GE/RCA

Lawrence C. Ellery Jr., 63, on December 28. He was a self-employed

professional quality engineer.

Marcos A. Carrasquillo Rabelo, 63, on December 30. He worked at the

Nassau Inn.

Raymond A. Hartmann Sr., 59, on January 1. He was a telecommunications

analyst at New Jersey Manufacturers Insurance Company.

Nicholas A. Mastoris, 87, on January 3. He and his wife founded

Mastoris Diner Restaurant in Bordentown.


Next Story


Corrections or additions?


This page is published by PrincetonInfo.com

— the web site for U.S. 1 Newspaper in Princeton, New Jersey.

Facebook Comments